WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'1201 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 5'1001 Child (under 5 years) mortality rate: 302

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 15'083  14'707  14'342  13'989  13'648  11'204  8'890  7'001 
Births 474  469  463  458  452  412  349  302 
Surviving infants 463  457  451  445  439  395  328  276 
Pop. less than 5 years 2'215  2'184  2'161  2'134  2'113  1'859  1'517  1'262 
Pop. less than 15 years 6'151  6'050  5'955  5'856  5'763  4'937  4'034  3'177 
Female 15-49 years 3'760  3'647  3'534  3'428  3'323  2'621  1'952  1'545 

Number of reported case

(Click for retrospective incidence data for Guatemala)
Diphtheria
Japanese encephalitis
Measles 8'802  2'703 
Mumps 143  627 
Pertussis 273  60  146  130  1'513 
Polio* 287 
Rubella 276 
Rubella (CRS)
Tetanus (neonatal) 60 
Tetanus (total) 11  60  60 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guatemala)
Vaccine year result method % card seen                                                
BCG 2007  97  MCH   86.7  94  91  100  93  99  95  62  36 
DTP1 2007  96  MCH   86.7  99*  94  97  94  100  94 
DTP3 2007  84  MCH   86.7  96  88  94  92  95  95  66  43 
HepB_BD          35  31  15 
HepB3          96  88  94  92  95 
Hib3          96  88  94  92  95 
JapEnc         
MCV          93  89  93  92  96  86  68  23 
MCV2          59 
PCV1         
PCV3         
Pol3 2007  85  MCH   86.7  94  88  94  92  96  93  74  43 
Rota1          99*  81  30 
Rota_last          81  71  38 
Rubella1          93  89  93  92  96 
TT2plus 2001  49  MCH   68.6  99*  22  27 
PAB         
VAD1          34  63  82  36  66  49 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guatemala)
BCG 94  91  99  93  99  95  62  36 
DTP1 98  94  96  94  99  94  86  68 
DTP3 96  88  94  92  95  81  66  43 
HepB3 96  88  94  92  95 
Hib3 96  85  94  92  95 
MCV 93  89  93  92  96  86  68  23 
PAB 85  85  85  71  71  67  44 
PCV3
Pol3 94  88  94  92  96  80  74  43 
Rota_last 81  71  38 

Number of districts in the country 334  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 72
From 80 to 89% 19
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB birth; Yes and 3 doses for adults in risk groups
Influenza 6 months to 5 years; > 18 years; risk groups
MMR 12 months; Yes
MR > 14 years; Yes travelers and risk groups
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4 months; 1 year; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 year; Yes or 1st contact; +4 weeks; +6 months; +10, +10 years (if not at risk)
VitaminA 6-59, 12-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  No  Yes  No  No  No  Yes 
What years does the MYP cover? number 2012-2016    2011-2015        2002-2006 
Nº of districts with microplans that include activities to raise immunization coverage number   335  332  333  332   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 334  335  332  333  332  332  331 
Nº districts with DTP3 coverage >=80% number 305  256  266  263  312  304  293 
% of districts with DTP3 coverage >=80% From 0 to 100% 91  73  80  79  94  92  89 
Nº districts with measles (MCV1) coverage >=95% number 130  71  179  162  231     
% of districts with MCV1 coverage >=95% From 0 to 100% 39  21  54  49  70     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  99     

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.